التفاصيل البيبلوغرافية
| العنوان: |
A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma |
| المؤلفون: |
Enzler, T., Nguyen, A., Misleh, J., Cline, V.J., Johns, M., Shumway, N., Paulson, S., Siegel, R., Larson, T., Messersmith, W., Richards, D., Chaves, J., Pierce, E., Zalupski, M., Sahai, V., Orr, D., Ruste, S.A., Haun, A., Kawabe, T. |
| المصدر: |
In European Journal of Cancer April 2024 201 |
| قاعدة البيانات: |
ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder